Tingyi Li - Annovis BioInc Vice President
| ANVS Stock | USD 9.85 0.86 9.57% |
President
Mr. Tingyi Li is Vice President of Anv Security Group Inc. He has over 10 years experience in RD, Market Sales and manufacture of security products and solutions in China. He was the founder, president and primary shareholder of Shenzhen ANGESI Science Co., Ltd. since 2012.
| Age | 38 |
| Tenure | 12 years |
| Address | 1055 Westlakes Drive, Berwyn, PA, United States, 19312 |
| Phone | 610 727 3913 |
| Web | https://www.annovisbio.com |
Annovis BioInc Management Efficiency
The company has return on total asset (ROA) of (1.2177) % which means that it has lost $1.2177 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.464) %, meaning that it created substantial loss on money invested by shareholders. Annovis BioInc's management efficiency ratios could be used to measure how well Annovis BioInc manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to gain to 7.61 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (5.23). At this time, Annovis BioInc's Total Assets are comparatively stable compared to the past year. Net Tangible Assets is likely to gain to about 53.7 M in 2024, despite the fact that Return On Tangible Assets are likely to grow to (5.23).Similar Executives
| Found 1 records | PRESIDENT Age | ||
| Geoffrey OBrien | MediciNova | 48 | |
Management Performance
| Return On Equity | -5.46 | ||||
| Return On Asset | -1.22 |
Annovis BioInc Leadership Team
Elected by the shareholders, the Annovis BioInc's board of directors comprises two types of representatives: Annovis BioInc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Annovis. The board's role is to monitor Annovis BioInc's management team and ensure that shareholders' interests are well served. Annovis BioInc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Annovis BioInc's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kevin Su, CFO | ||
| Tingyi Li, Vice President | ||
| Reid McCarthy, Independent Director | ||
| Cheng Fang, Senior Development | ||
| Melissa Gaines, Senior Operations | ||
| Mark White, Independent Director | ||
| Yiquan Song, Director | ||
| Michael Hoffman, Independent Director Chairman of the Board | ||
| Paul Strickland, Independent Director | ||
| Jeffrey McGroarty, Chief Financial Officer | ||
| RAC MS, Senior Operations | ||
| Claudine Bruck, Independent Director | ||
| Maria Maccecchini, President, Chief Executive Officer, Founder, Director | ||
| MBA III, Chief Officer | ||
| Humayun Shakeel, IR Contact Officer | ||
| Weixing Wang, Chairman, CEO and Pres |
Annovis Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Annovis BioInc a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -5.46 | ||||
| Return On Asset | -1.22 | ||||
| Current Valuation | 105.24 M | ||||
| Shares Outstanding | 11.01 M | ||||
| Shares Owned By Insiders | 24.59 % | ||||
| Shares Owned By Institutions | 11.49 % | ||||
| Number Of Shares Shorted | 1.5 M | ||||
| Price To Earning | (0.43) X | ||||
| Price To Book | 19.68 X | ||||
| EBITDA | (45.04 M) |
Pair Trading with Annovis BioInc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Annovis BioInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annovis BioInc will appreciate offsetting losses from the drop in the long position's value.Moving against Annovis Stock
| 0.54 | MRSN | Mersana Therapeutics Downward Rally | PairCorr |
| 0.49 | GRTX | Galera Therapeutics Financial Report 9th of May 2024 | PairCorr |
| 0.45 | EOLS | Evolus Inc Financial Report 14th of May 2024 | PairCorr |
The ability to find closely correlated positions to Annovis BioInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Annovis BioInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Annovis BioInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Annovis BioInc to buy it.
The correlation of Annovis BioInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Annovis BioInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Annovis BioInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Annovis BioInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Annovis BioInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For more information on how to buy Annovis Stock please use our How to Invest in Annovis BioInc guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Complementary Tools for Annovis Stock analysis
When running Annovis BioInc's price analysis, check to measure Annovis BioInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis BioInc is operating at the current time. Most of Annovis BioInc's value examination focuses on studying past and present price action to predict the probability of Annovis BioInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annovis BioInc's price. Additionally, you may evaluate how the addition of Annovis BioInc to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |
Is Annovis BioInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Annovis BioInc. If investors know Annovis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Annovis BioInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.23) | Return On Assets (1.22) | Return On Equity (5.46) |
The market value of Annovis BioInc is measured differently than its book value, which is the value of Annovis that is recorded on the company's balance sheet. Investors also form their own opinion of Annovis BioInc's value that differs from its market value or its book value, called intrinsic value, which is Annovis BioInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Annovis BioInc's market value can be influenced by many factors that don't directly affect Annovis BioInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Annovis BioInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Annovis BioInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Annovis BioInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.